Plicamycin

• 产品号: Plicamycin
• CAS号: 18378-89-7
• 分子式: C52H76O24
• 分子量: 1085.14544

产品别名

• 标题: Plicamycin
• IUPAC标准名: (2S)-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-2-{[(2S,4R,5R,6R)-4-{[(2S,4R,5R,6R)-4-{[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-6-{[(2S,4R,5S,6R)-4-{[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-7-methyl-1,2,3,4-tetrahydroanthracen-1-one
• IUPAC传统名: plicamycin
• 别名: Mithramycin A; Plicatomycin; Aureolic acid; Mithracin; Antibiotic LA 7017; Mitramycin

产品登记号

• 美国药典/FDA物质标识码: NIJ123W41V
• CHEMBL: 509846
• 维基百科标题: Plicamycin
• PubChem CID: 5284610
• Chemspider ID: 4447655
• ATC码: L01DC02
• KEGG ID: D00468
• CAS号: 18378-89-7
• DrugBank ID: DB06810

产品性质

• 给药途径: Intravenous
• 法定药品分级: discontinued
• 法定药品分级: Rx-only (US)
• 妊娠期药物分类: X (US)